Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study.
Paroli M, Becciolini A, Bravi E, Andracco R, Nucera V, Parisi S, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Lo Gullo A, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, Di Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, De Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, Franchina V, Molica Colella F, Ferrero G, Ariani A. Paroli M, et al. Among authors: bruzzese v. Medicina (Kaunas). 2023 Aug 17;59(8):1480. doi: 10.3390/medicina59081480. Medicina (Kaunas). 2023. PMID: 37629770 Free PMC article.
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
Farroni C, Aiello A, Picchianti-Diamanti A, Laganà B, Petruccioli E, Agrati C, Garbuglia AR, Meschi S, Lapa D, Cuzzi G, Petrone L, Vanini V, Salmi A, Altera AMG, Repele F, Grassi G, Bettini A, Vita S, Mariano A, Damiani A, Infantino M, Grossi V, Manfredi M, Niccoli L, Puro V, Rosa RD, Salemi S, Sesti G, Scolieri P, Bruzzese V, Benucci M, Cantini F, Nicastri E, Goletti D. Farroni C, et al. Among authors: bruzzese v. Int J Infect Dis. 2022 Dec;125:195-208. doi: 10.1016/j.ijid.2022.10.035. Epub 2022 Nov 1. Int J Infect Dis. 2022. PMID: 36328289 Free PMC article.
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study.
Becciolini A, Parisi S, Del Medico P, Farina A, Visalli E, Molica Colella AB, Lumetti F, Caccavale R, Scolieri P, Andracco R, Girelli F, Bravi E, Colina M, Volpe A, Ianniello A, Ditto MC, Nucera V, Franchina V, Platè I, Donato ED, Amato G, Salvarani C, Bernardi S, Lucchini G, De Lucia F, Molica Colella F, Santilli D, Mansueto N, Ferrero G, Marchetta A, Arrigoni E, Foti R, Sandri G, Bruzzese V, Paroli M, Fusaro E, Ariani A. Becciolini A, et al. Among authors: bruzzese v. Biomedicines. 2023 Feb 2;11(2):433. doi: 10.3390/biomedicines11020433. Biomedicines. 2023. PMID: 36830969 Free PMC article.
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis.
Picchianti Diamanti A, Navarra A, Cuzzi G, Aiello A, Salemi S, Di Rosa R, De Lorenzo C, Vio D, Sebastiani G, Ferraioli M, Benucci M, Li Gobbi F, Cantini F, Polidori V, Simmaco M, Cialdi E, Scolieri P, Bruzzese V, Nicastri E, D'Amelio R, Laganà B, Goletti D. Picchianti Diamanti A, et al. Among authors: bruzzese v. Biomedicines. 2023 Feb 23;11(3):687. doi: 10.3390/biomedicines11030687. Biomedicines. 2023. PMID: 36979666 Free PMC article.
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study.
Lo Gullo A, Becciolini A, Parisi S, Del Medico P, Farina A, Visalli E, Dal Bosco Y, Molica Colella AB, Lumetti F, Caccavale R, Scolieri P, Andracco R, Girelli F, Bravi E, Colina M, Volpe A, Ianniello A, Ditto MC, Nucera V, Franchina V, Platé I, Di Donato E, Amato G, Salvarani C, Bernardi S, Lucchini G, De Lucia F, Molica Colella F, Santilli D, Mansueto N, Ferrero G, Marchetta A, Arrigoni E, Foti R, Sandri G, Bruzzese V, Paroli M, Fusaro E, Ariani A. Lo Gullo A, et al. Among authors: bruzzese v. J Clin Med. 2023 Jun 7;12(12):3892. doi: 10.3390/jcm12123892. J Clin Med. 2023. PMID: 37373587 Free PMC article.
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies.
Gioia C, Picchianti Diamanti A, Perricone R, Chimenti MS, Afeltra A, Navarini L, Migliore A, Massafra U, Bruzzese V, Scolieri P, Meschini C, Paroli M, Caccavale R, Scapato P, Scrivo R, Conti F, Laganà B, Di Franco M. Gioia C, et al. Among authors: bruzzese v. Reumatismo. 2023 Dec 19;75(4). doi: 10.4081/reumatismo.2023.1602. Reumatismo. 2023. PMID: 38115772 Free article.
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis.
Lo Gullo A, Parisi S, Becciolini A, Paroli M, Bravi E, Andracco R, Nucera V, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, DI Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, DE Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, DE Andres MI, Franchina V, Molica Colella F, Ferrero G, Ariani A. Lo Gullo A, et al. Among authors: bruzzese v. Minerva Med. 2024 Aug;115(4):430-438. doi: 10.23736/S0026-4806.24.09409-6. Minerva Med. 2024. PMID: 39376099
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.
De Lorenzis E, Parente P, Natalello G, Soldati S, Bosello SL, Barbara A, Sorge C, Axelrod S, Verardi L, Cerasuolo PG, Peluso G, Gemma A, Davoli M, Biliotti D, Bruzzese V, Goletti M, Di Martino M, D'Agostino MA. De Lorenzis E, et al. Among authors: bruzzese v. Joint Bone Spine. 2023 Mar;90(2):105497. doi: 10.1016/j.jbspin.2022.105497. Epub 2022 Nov 21. Joint Bone Spine. 2023. PMID: 36423782 Free PMC article. No abstract available.
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy.
Paroli M, Becciolini A, Lo Gullo A, Parisi S, Bravi E, Andracco R, Nucera V, Ometto F, Lumetti F, Farina A, Del Medico P, Colina M, Ravagnani V, Scolieri P, Larosa M, Priora M, Visalli E, Addimanda O, Vitetta R, Volpe A, Bezzi A, Girelli F, Molica Colella AB, Caccavale R, Di Donato E, Adorni G, Santilli D, Lucchini G, Arrigoni E, Platè I, Mansueto N, Ianniello A, Fusaro E, Ditto MC, Bruzzese V, Camellino D, Bianchi G, Serale F, Foti R, Amato G, De Lucia F, Dal Bosco Y, Foti R, Reta M, Fiorenza A, Rovera G, Marchetta A, Focherini MC, Mascella F, Bernardi S, Sandri G, Giuggioli D, Salvarani C, De Andres MI, Franchina V, Molica Colella F, Ferrero G, Raffeiner B, Ariani A. Paroli M, et al. Among authors: bruzzese v. J Clin Med. 2024 Jul 4;13(13):3929. doi: 10.3390/jcm13133929. J Clin Med. 2024. PMID: 38999494 Free PMC article.
98 results